Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
23 Visninger
• 07/30/23
0
0
Indlejre
administrator
Abonnenter
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer